Castle Biosciences Inc.

63.22-3.00-4.53%Vol 152.14K1Y Perf 58.85%
Jul 27th, 2021 14:46 DELAYED
BID63.10 ASK63.34
Open66.01 Previous Close66.22
Pre-Market- After-Market-
 - -%  - -
Target Price
87.75 
Analyst Rating
Strong Buy 1.00
Potential %
38.80 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★+     58.64
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★     58.28
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap1.58B 
Earnings Rating
Price Range Ratio 52W %
37.84 
Earnings Date
9th Aug 2021

Today's Price Range

62.1166.12

52W Range

36.15107.69

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-1.30%
1 Month
-9.76%
3 Months
-6.76%
6 Months
2.21%
1 Year
58.85%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CSTL63.22-3.0000-4.53
AAPL146.66-2.3300-1.56
GOOG2 727.84-65.0500-2.33
MSFT285.52-3.5300-1.22
XOM57.69-0.7900-1.35
WFC45.100.09000.20
JNJ172.150.28000.16
FB366.67-5.7900-1.55
GE13.120.20001.55
JPM151.62-0.0300-0.02
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.22-0.1722.73
Q04 2020-0.11-0.16-45.45
Q03 2020-0.06-0.23-283.33
Q02 2020-0.42-0.0880.95
Q01 2020-0.120.03125.00
Q04 2019-0.200.11155.00
Q03 2019-0.31-0.310.00
Q02 2019-0.52-1.05-101.92
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date9th Aug 2021
Estimated EPS Next Report-0.29
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume152.14K
Shares Outstanding25.06M
Trades Count3.36K
Dollar Volume23.00M
Avg. Volume275.62K
Avg. Weekly Volume117.35K
Avg. Monthly Volume172.65K
Avg. Quarterly Volume247.12K

Castle Biosciences Inc. (NASDAQ: CSTL) stock closed at 66.22 per share at the end of the most recent trading day (a -3.75% change compared to the prior day closing price) with a volume of 106.72K shares and market capitalization of 1.58B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 135 people. Castle Biosciences Inc. CEO is Derek J. Maetzold.

The one-year performance of Castle Biosciences Inc. stock is 58.85%, while year-to-date (YTD) performance is -1.38%. CSTL stock has a five-year performance of %. Its 52-week range is between 36.15 and 107.69, which gives CSTL stock a 52-week price range ratio of 37.84%

Castle Biosciences Inc. currently has a PE ratio of -94.20, a price-to-book (PB) ratio of 4.12, a price-to-sale (PS) ratio of 31.16, a price to cashflow ratio of 220.80, a PEG ratio of 2.32, a ROA of -5.43%, a ROC of -5.55% and a ROE of -5.98%. The company’s profit margin is -24.87%, its EBITDA margin is -18.50%, and its revenue ttm is $55.33 Million , which makes it $2.21 revenue per share.

Of the last four earnings reports from Castle Biosciences Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.29 for the next earnings report. Castle Biosciences Inc.’s next earnings report date is 09th Aug 2021.

The consensus rating of Wall Street analysts for Castle Biosciences Inc. is Strong Buy (1), with a target price of $87.75, which is +38.80% compared to the current price. The earnings rating for Castle Biosciences Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Castle Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Castle Biosciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 15.47, ATR14 : 3.32, CCI20 : -64.74, Chaikin Money Flow : 0.07, MACD : -0.76, Money Flow Index : 35.73, ROC : -6.68, RSI : 43.17, STOCH (14,3) : 24.21, STOCH RSI : 0.44, UO : 59.41, Williams %R : -75.79), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Castle Biosciences Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Castle Biosciences Inc.

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.

CEO: Derek J. Maetzold

Telephone: +1 866 788-9007

Address: 820 S. Friendswood Drive, Friendswood 77546, TX, US

Number of employees: 135

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

48%52%

News

Stocktwits